Chemoinformaics analysis of (Z)-alpha-Bisabolene
| Molecular Weight | 204.357 | nRot | 3 |
| Heavy Atom Molecular Weight | 180.165 | nRig | 8 |
| Exact Molecular Weight | 204.188 | nRing | 1 |
| Solubility: LogS | -5.814 | nHRing | 0 |
| Solubility: LogP | 6.581 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 39 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 41.053 |
| nHD | 0 | BPOL | 24.077 |
| QED | 0.565 |
| Synth | 3.496 |
| Natural Product Likeliness | 2.65 |
| NR-PPAR-gamma | 0.005 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.129 |
| Pgp-sub | 0.001 |
| HIA | 0.007 |
| CACO-2 | -4.502 |
| MDCK | 0.000014 |
| BBB | 0.212 |
| PPB | 0.925185 |
| VDSS | 6.444 |
| FU | 0.0502623 |
| CYP1A2-inh | 0.939 |
| CYP1A2-sub | 0.204 |
| CYP2c19-inh | 0.605 |
| CYP2c19-sub | 0.681 |
| CYP2c9-inh | 0.577 |
| CYP2c9-sub | 0.841 |
| CYP2d6-inh | 0.194 |
| CYP2d6-sub | 0.415 |
| CYP3a4-inh | 0.434 |
| CYP3a4-sub | 0.225 |
| CL | 17.581 |
| T12 | 0.092 |
| hERG | 0.014 |
| Ames | 0.012 |
| ROA | 0.01 |
| SkinSen | 0.906 |
| Carcinogencity | 0.791 |
| EI | 0.973 |
| Respiratory | 0.098 |
| NR-Aromatase | 0.009 |
| Antiviral | Yes |
| Prediction | 0.80714 |